US HB1754 | 2019-2020 | 116th Congress
Status
Spectrum: Moderate Partisan Bill (Democrat 207-55)
Status: Engrossed on September 30 2020 - 50% progression, died in chamber
Action: 2020-09-30 - Received in the Senate.
Text: Latest bill text (Engrossed) [PDF]
Status: Engrossed on September 30 2020 - 50% progression, died in chamber
Action: 2020-09-30 - Received in the Senate.
Text: Latest bill text (Engrossed) [PDF]
Summary
Recognizes the Horseracing Integrity and Safety Authority for purposes of developing and implementing a horseracing anti-doping and medication control program and a racetrack safety program. The authority shall establish an anti-doping and medication control standing committee and a racetrack safety standing committee to provide guidance to the authority on the development and maintenance of the programs. The Federal Trade Commission (FTC) shall have oversight over the authority. The authority shall submit to the FTC any proposed rule, standard, or procedure developed by the authority to carry out the horseracing anti-doping and medication control program or the racetrack safety program. The authority shall seek to enter into an agreement with the U.S. Anti-Doping Agency or an entity equal in qualification under which the entity acts as the anti-doping and medication control enforcement agency under this bill. Among the required elements of the horseracing safety program are sets of training and racing safety standards consistent with the humane treatment of horses, a system to maintain track surface quality, programs for injury and fatality analysis, investigation and disciplinary procedures, and an evaluation and accreditation program. The bill sets forth other provisions regarding (1) funding, conflicts of interest, and jurisdiction; (2) registration with the authority; (3) program enforcement; (4) rule violations and civil sanctions; (5) testing laboratories; (6) review of final decisions of the authority by an administrative law judge; (7) unfair or deceptive acts or practices; and (8) agreements with state racing commissions.
Title
Horseracing Integrity and Safety Act of 2020
Sponsors
History
Date | Chamber | Action |
---|---|---|
2020-09-30 | Senate | Received in the Senate. |
2020-09-29 | House | Motion to reconsider laid on the table Agreed to without objection. |
2020-09-29 | House | On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4973-4980) |
2020-09-29 | House | Placed on the Union Calendar, Calendar No. 454. |
2020-09-29 | House | Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-554. |
2020-09-29 | House | DEBATE - The House proceeded with forty minutes of debate on H.R. 1754. |
2020-09-29 | House | Considered under suspension of the rules. (consideration: CR H4973-4983) |
2020-09-29 | House | Mr. Pallone moved to suspend the rules and pass the bill, as amended. |
2020-09-09 | House | Ordered to be Reported (Amended) by the Yeas and Nays: 46 - 5. |
2020-09-09 | House | Committee Consideration and Mark-up Session Held. |
2019-03-15 | House | Referred to the Subcommittee on Consumer Protection and Commerce. |
2019-03-14 | House | Referred to the House Committee on Energy and Commerce. |
2019-03-14 | House | Introduced in House |
Same As/Similar To
SB1820 (Related) 2019-06-12 - Read twice and referred to the Committee on Commerce, Science, and Transportation.
SB4547 (Related) 2020-09-09 - Read twice and referred to the Committee on Commerce, Science, and Transportation. (Sponsor introductory remarks on measure: CR S5514-5515; text: CR S5515-5521)
HB2336 (Related) 2019-08-23 - Became Public Law No: 116-51. (TXT | PDF)
SB4547 (Related) 2020-09-09 - Read twice and referred to the Committee on Commerce, Science, and Transportation. (Sponsor introductory remarks on measure: CR S5514-5515; text: CR S5515-5521)
HB2336 (Related) 2019-08-23 - Became Public Law No: 116-51. (TXT | PDF)
Subjects
Administrative law and regulatory procedures
Administrative remedies
Advisory bodies
Animal protection and human-animal relationships
Athletes
Business ethics
Civil actions and liability
Congressional oversight
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Federal Trade Commission (FTC)
Fraud offenses and financial crimes
Gambling
Government studies and investigations
Health information and medical records
Intergovernmental relations
Mammals
Medical ethics
Medical research
Medical tests and diagnostic methods
Professional sports
Sports and recreation
Sports and recreation facilities
State and local government operations
Veterinary medicine and animal diseases
Administrative remedies
Advisory bodies
Animal protection and human-animal relationships
Athletes
Business ethics
Civil actions and liability
Congressional oversight
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Federal Trade Commission (FTC)
Fraud offenses and financial crimes
Gambling
Government studies and investigations
Health information and medical records
Intergovernmental relations
Mammals
Medical ethics
Medical research
Medical tests and diagnostic methods
Professional sports
Sports and recreation
Sports and recreation facilities
State and local government operations
Veterinary medicine and animal diseases